A new study published at the end of 2025 suggests that cannabidiol (CBD) could play an important role in future cancer treatments.
According to researchers, this non-psychotropic cannabinoid has “considerable potential as an antitumor agent” due to its ability to interfere with several biological mechanisms that allow tumors to grow, spread, and resist treatment.
The study, funded by the National Natural Science Foundation of China and published in the journal Phytomedicine, analyzed a wide range of preclinical studies examining the effects of CBD on various forms of cancer. Although the article has not yet been peer-reviewed, it adds to a growing number of publications exploring cannabinoids beyond symptom management.
How CBD interacts with cancer cells
“CBD exhibits multi-targeted anti-tumor effects by disrupting key characteristics of cancer,” the authors write.
Rather than acting on a single pathway, CBD appears to influence several biological systems simultaneously. Cancer cells often survive by hijacking normal cellular signals related to growth, stress management, and immune response. The novelty highlighted in the study is that CBD appears to act simultaneously on several of these systems, increasing pressure on tumor cells until they
TO CONTINUE READING: Newsweed
